Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company (TSE:4502/NYSE:TAK) (“Takeda”) to acquire the TachoSil manufacturing operations in Linz, Austria. Corza Medical had previously acquired the commercial product rights for TachoSil, a best-in-class surgical patch trusted by medical professionals worldwide, in January 2021. The acquisition of the TachoSil manufacturing operations will benefit customers and employees, as TachoSil’s experienced manufacturing teams and extensive production knowledge will be complemented by Corza Medical’s surgical focus, global commercial expertise, entrepreneurial culture, and infrastructure to scale for significant growth.
Read the full article: Corza Medical Signs Definitive Agreement to Acquire Takeda’s TachoSil Manufacturing Operations //
Source: https://www.globenewswire.com/news-release/2023/04/26/2655191/0/en/Corza-Medical-Signs-Definitive-Agreement-to-Acquire-Takeda-s-TachoSil-Manufacturing-Operations.html